ArticleBMC chemistry2024

Oxindole-benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation.

Heba T Abdel-MohsenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.